Two Sigma Securities
APVO icon

Two Sigma Securities’s Aptevo Therapeutics APVO Stock Holding History

Two Sigma Securities’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$5.04K – 1683
2024
Q3 		$5.04K Buy
+2
New +$9.21K ﹤0.01% 2668
2024
Q1 		– Hold
0
– -$2.04K – 2944
2023
Q4 		– Hold
0
– – – 2923
2023
Q1 		– Hold
0
– -$34.5K – 2627
2022
Q4 		– Hold
0
– – – 2208
2019
Q3 		– Hold
0
– -$13K – 2040
2019
Q2 		– Hold
0
– – – 1977
2019
Q1 		– Hold
0
– – – 1692
2018
Q1 		– Hold
0
– -$56K – 2655
2017
Q4 		– Hold
0
– – – 1512

Other funds holding APVO

Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Diadema Partners
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Center for Financial Planning
Center for Financial Planning Southfied, Michigan $1.08B AUM 12.2% 1-Year Est. Return

Two Sigma Securities's APVO Position: Q4 2024 in Review

Two Sigma Securities sold out of Aptevo Therapeutics (APVO) in Q4 2024, closing a stake of 2 shares — an estimated $5.04K sold.

Two Sigma Securities first reported a position in APVO in Q3 2024 and held it in 1 quarter. The position peaked at $5.04K in Q3 2024. 7 funds tracked by Wall St. Rank hold APVO as of Q4 2024.

  • Two Sigma Securities reported no remaining Aptevo Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 2 Aptevo Therapeutics shares in Q4 2024, an estimated $5.04K.
  • Two Sigma Securities first reported a position in Aptevo Therapeutics in Q3 2024 and held it in 1 quarter.
  • Two Sigma Securities's Aptevo Therapeutics position peaked at $5.04K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.